Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 16.6B | 14.6B | 15.6B | 15.7B |
Cost of revenue | 14.6B | 13.5B | 14.0B | 14.2B |
Gross profit | 2.0B | 1.2B | 1.6B | 1.5B |
Operating expense | ||||
Research & development | 245.7M | 221.1M | 164.8M | 128.6M |
Selling general and admin | 336.4M | 590.9M | 348.4M | 282.0M |
Other operating expenses | 22.0M | 102.4M | 48.6M | 61.3M |
Operating income | 134.1M | -989.0M | -82.7M | -17.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 96.4M | -186.3M | -9.7M | 89.9M |
Tax provision | 19.3M | -367.4M | -10.0M | 18.5M |
Net income | 77.1M | 181.1M | 375.4K | 71.4M |
Basic EPS | 3 | — | -0.2 | 2 |
Diluted EPS | 3 | — | -0.2 | 2 |
Basic average shares | — | — | — | 35.7M |
Diluted average shares | — | — | — | 35.7M |
EBITDA | 384.0M | 352.3M | 52.1M | 99.6M |
Net income from continuing op. | 96.4M | -186.3M | — | 89.9M |
Minority interests | 8.8M | 11.5M | -5.9M | — |
Preferred stock dividends | — | — | — | — |